Excitement in synovium: the rapid evolution of understanding of rheumatoid arthritis and expectations for therapy
Harris, E.D.
Journal of Rheumatology. Suppl 32 3-5; Discussion: 5-6
1992
ISSN/ISBN: 0380-0903 PMID: 1613730 Document Number: 400783
Multiple events give rise to rheumatoid arthritis (RA) and many different elements create an overall pathological effect. It is highly unlikely that a single cause for RA will be identified. A greater appreciation of the multiple events that lead to the development of RA is opening up a number of promising points of intervention which may serve as potential alternatives to the broader-based and often toxic drugs used in RA therapy today.
Document emailed within 1 workday
Related Documents
Peterlana, D.; Puccetti, A.; Beri, R.; Ricci, M.; Simeoni, S.; Borgato, L.; Scilanga, L.; Cerù, S.; Corrocher, R.; Lunardi, C. 2003: The presence of parvovirus B19 VP and NS1 genes in the synovium is not correlated with rheumatoid arthritis Journal of Rheumatology 30(9): 1907-1910Lindström, F.D. 1970: Kappa:lambda light chain ratio in IgG eluted from rheumatoid arthritis synovium Clinical and Experimental Immunology 7(1): 1-10
Jones, V.E.; Jacoby, R.K.; Cowley, P.J.; Warren, C. 1982: Immune complexes in early arthritis. II. Immune complex constituents are synthesized in the synovium before rheumatoid factors Clinical and Experimental Immunology 49(1): 31-40
Dessein, P.H.; Stanwix, A.E.; Meyers, O.L. 1992: Rheumatoid arthritis--will better understanding of its pathogenesis lead to better treatment? South African Medical Journal 81(7): 344-346
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Jung, S.M.; Schumacher, H.R. 2005: Can characterization by traditional Korean medical criteria help in our understanding of patients with rheumatoid arthritis? Clinical and Experimental Rheumatology 23(5): 729-730
Trentham, D.E. 1984: Strategies for medical treatment based on current understanding of the pathogenesis of rheumatoid arthritis Clinical Orthopaedics and Related Research 182: 31-36
Poma, A.; Carlucci, G.; Fontecchio, G. 2012: Immunogenetics and HPLC analyses contribute to understanding the etiopathology of rheumatoid arthritis through studies on ancient human remains International Journal of Immunopathology and Pharmacology 25(4): 1075-1082
Umeki, S.; Sumi, M.; Soejima, R. 1993: A case of rheumatoid arthritis accompanied by repeated pleural effusion associated with rapid tapering of steroid Nihon Kyobu Shikkan Gakkai Zasshi 31(2): 225-230
Benenson, E.V.; Tsaĭ, E.G. 1990: The rapid cytofluorometric indices of lymphocyte functional activity in rheumatoid arthritis and systemic lupus erythematosus Terapevticheskii Arkhiv 62(5): 22-27
Sumida, T.; Hoa, T.T.; Asahara, H.; Hasunuma, T.; Nishioka, K. 1997: T cell receptor of Fas-sensitive T cells in rheumatoid synovium Journal of Immunology 158(4): 1965-1970
Migita, K.; Yamasaki, S.; Ida, H.; Kita, M.; Hida, A.; Shibatomi, K.; Kawakami, A.; Aoyagi, T.; Eguchi, K. 2002: The role of peroxynitrite in cyclooxygenase-2 expression of rheumatoid synovium Clinical and Experimental Rheumatology 20(1): 59-62
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162
Barrera, P.; Balsa, A.; Alves, H.; Westhovens, R.; Maenaut, K.; Cornélis, F.; Fritz, P.; Bardin, T.; Ceu Maia, M.; Lopes-Vaz, A.; Pascual Salcedo, D.; de la Concha, E.; Radstake, T.; van de Putte, L.B.; Migliorini, P.; Prudhomme, J.F.; Charron, D.; Spyropoulou, M.; Mendes, A.; Spaepen, M.; Martinez, M.; Stavropoulos, C. 2001: Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF) Journal of Rheumatology 28(5): 968-974
Chen, J.R.; Takahashi, M.; Suzuki, M.; Kushida, K.; Miyamoto, S.; Inoue, T. 1998: Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis Journal of Rheumatology 25(12): 2440-2444
Scherler, M. 1978: Poncet--rheumatoid arthritis. Four cases of rheumatoid arthritis treated with tuberculostatics (author's transl1 Therapeutische Umschau. Revue Therapeutique 35(3): 201-206
Keitel, W.; Keitel, R. 1999: Basic therapy of rheumatoid arthritis. 2: Selection, long-term and combination therapy MMW Fortschritte der Medizin 141(37): 42-44
Suzuki, K.; Takeuchi, T. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Towards precision medicine in rheumatoid arthritis Clinical Calcium 28(5): 626-629
Yamanaka, H. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. how to use the guideline in the management of rheumatoid arthritis Clinical Calcium 28(5): 607-610